- Increasing growth funding, even during a downturn in the market
- Accelerating clinical trials and trial assurance
- Expanding health equity through artificial intelligence (AI)
2023 J.P. Morgan Health Care Conference
RELAX, MIX WITH COLLEAGUES, AND ENJOY COCKTAILS ON US
Join Arthur D. Little’s healthcare industry experts for an evening of informal conversation about funding new growth initiatives, clinical trial assurance, healthcare equity, and more, at SWIG. You'll enjoy a custom menu designed by Chef Michele Ledoux, who uses the finest locally sourced, sustainably farmed organic ingredients; and cocktails created by the skilled bartenders at SWIG, featuring pressed juices and garnishes, an extensive collection of fine spirits, quality craft beers, and fine California wines.
ABOUT THE J.P. MORGAN HEALTHCARE CONFERENCE
As the largest and most informative life sciences investment gathering in the industry, connecting global industry leaders, emerging fast growth companies, innovative technology creators, and members of the investment community, the JPM Healthcare Conference is a must-attend week to connect, tell your stories to investors, strike deals, and mix with colleagues.
VENUE INFORMATION
JOIN US AT SWIG
561 Geary St, San Francisco, CA 94102
January 10, 18:00 -21:00
Located just off Union Square in the heart of San Francisco, SWIG is the city’s quintessential modern classic bar. Its inviting, contemporary decor is complemented by a serious collection of the finest spirits and libations, perfectly served by a professional, energetic and knowledgeable crew.
Great music is central to the Swig experience. Catering by private chef Michele Ledoux of Chez Michele (chezmichele.com), who studied with some of the world's finest chefs from France, Italy, Germany, Japan, and the U.S., adds to the experience, with a menu featuring delicacies made with organic and sustainably sourced ingredients.
ARTHUR D. LITTLE’S HEALTHCARE AND LIFE SCIENCES TEAM
CONVERSATION AND NETWORKING
Arthur D. Little’s health care industry experts look forward to talking with you about the trends and innovations that are having a profound impact on healthcare industry investments, including:
Funding growth initiatives in complex environments
Economic headwinds will make it more difficult for companies to sustain growth. Start-ups are facing more challenges in securing funding, while established companies are experiencing cost-cutting pressures. Funding new growth initiatives is expected to become more difficult due to the higher cost of capital and the pressure to pay down corporate debt.
Despite the challenging economic outlook, ADL’s 2022 Global CEO Survey reveals that most executives plan to maintain or increase growth funding in 2023, and they expect a broader set of strategies for achieving growth. Join us to discuss growth trends that will shift the industry and differentiate the growth leaders from the laggards.
Accelerating and assuring clinical trials
Successful and on-time clinical trials are critical to patients and trial sponsors alike, yet delays are too common and often extremely costly. While this is an age-old issue, we believe that a fresh look is now needed to identify innovative approaches and data-driven interventions that highlight the next best actions in addressing clinical trial challenges, including the identification of patients. Join us to learn about our work in accelerating clinical trials, even in complex disease areas.
Expanding health equity through AI
Health equity is now a major focus for life sciences stakeholders due to increasing Health Authority guidance, introduction of clinical trial regulations, and other pressures. Health equity is a complex issue; while race and ethnicity are key focus areas, several other dimensions of diversity also need to be considered, including age, biological sex, pregnancy status, sexual orientation, socio-economic status, underlying medical problems, etc.
ADL believes that AI/ML-based techniques can be leveraged to assess key barriers to health equity, providing data-driven actionable insights rather than relying solely on human guesses. Join us to discuss this view.
VIEWPOINTS FROM ARTHUR D. LITTLE HEALTHCARE & LIFE SCIENCES
Read Arthur D. Little’s recent report on current and future transformation in healthcare, and the effect these far-reaching changes will have on the life sciences and insurance sectors.
The pandemic has shown the strengths and weaknesses of the global healthcare sector — and the opportunities that exist for improvement and transformation.
VENUE LOCATION
STILL HAVE QUESTIONS? GET IN TOUCH
<div style="text-align: center; font-size:22px"> Form submitted. Thank you! </div>
